Feasibility of Using Qualitative Interviews to Explore Patients’ Treatment Goals: Experience from Dermatology

Patient

Volumn 9, Issue 3, 2016, Pages 261-269

  Blome, Christine ^a   von Usslar, Kathrin ^a   Augustin, Matthias ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; COMPREHENSION; CONTENT ANALYSIS; CONTENT VALIDITY; DERMATOLOGY; FEASIBILITY STUDY; FEMALE; GOAL ATTAINMENT; HUMAN; LEG ULCER; LEISURE; MALE; MIDDLE AGED; PATIENT BENEFIT INDEX; PRIORITY JOURNAL; PSORIASIS; SEMI STRUCTURED INTERVIEW; SKIN DISEASE ASSESSMENT; TREATMENT PLANNING; VERY ELDERLY; VITILIGO; HEALTH LITERACY; INFORMATION PROCESSING; INTERVIEW; PATIENT CARE PLANNING; PATIENT PARTICIPATION; PROCEDURES; PSYCHOLOGY; QUALITATIVE RESEARCH; QUESTIONNAIRE; REPRODUCIBILITY; SKIN DISEASES;

ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; DERMATOLOGY; FEMALE; HEALTH LITERACY; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT CARE PLANNING; PATIENT PARTICIPATION; QUALITATIVE RESEARCH; REPRODUCIBILITY OF RESULTS; SKIN DISEASES; SURVEYS AND QUESTIONNAIRES;

EID: 84945530919     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-015-0149-5     Document Type: Article

References (32)

1. Brédart A, Marrel A, Abetz-Webb L, et al. Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience. Health Qual Life Outcomes. 2014;12:15.
2. Leidy NK, Vernon M. Perspectives on patient-reported outcomes. Pharmaco Economics. 2008;26:363–70.
3. Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1—eliciting concepts for a new PRO instrument. Value Health. 2011;14:967–77.
4. Fayers PM, Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. 2nd ed. Chichester: Wiley; 2007.
5. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2—assessing respondent understanding. Value Health. 2011;14(8):978–88.
6. Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcomes: instrument development and selection issues. Value Health. 2007;10(Suppl 2):S86–93.
7. Brod M, Tesler L, Christensen T. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18:1263–78.
8. Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003;12(3):229–38.
9. Kiresuk T, Sherman R. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J. 1968;4:443–53.
10. Gerdes N. Rehabilitationseffekte bei „zielorientierter Ergebnismessung“. Ergebnisse der IRES-ZOE-Studie 1996/97. Deutsche Rentenversicherung. 1998;3/4:217–38.
11. Feuerhahn J, Blome C, Radtke MA, et al. Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis. Arch Dermatol Res. 2012;304:433–41.
12. Augustin M, Blome C, Zschocke I, et al. Benefit evaluation in the therapy of chronic wounds from the patients’ perspective—development and validation of a new method. Wound Repair Regen. 2012;20:8–14.
13. Augustin M, Radtke MA, Zschocke I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res. 2009;301:561–71.
14. Augustin M, Reich C, Schaefer I, et al. Development and validation of a new instrument for the assessment of patient-defined benefit in the treatment of acne. J Dtsch Dermatol Ges. 2008;6:113–20.
15. Blome C, Maares J, Diepgen T, et al. Measurement of patient-relevant benefits in the treatment of chronic hand eczema—a novel approach. Contact Derm. 2009;61:39–45.
16. Blome C, Augustin M, Siepmann D, et al. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol. 2009;161:1143–8.
17. Augustin M, Schäfer I, Rabini S, et al. Assessing the value of supportive skin care: development and validation of an instrument for evaluating patient-relevant benefit. Dermatology. 2009;218:255–9.
18. Augustin M, Gajur AI, Reich C, et al. Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire. Dermatology. 2008;217:101–6.
19. Mrowietz U, Reich K. Psoriasis—new insights into pathogenesis and treatment. Dtsch Arzteblatt Int. 2009;106(1–2):11–8 (quiz 19).
20. Schäfer I, Rustenbach SJ, Radtke M, Augustin J, Glaeske G, Augustin M. Epidemiologie der psoriasis in Deutschland—Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung [Epidemiology of psoriasis in Germany—analysis of secondary health insurance data]. Das Gesundheitswesen. 2011;73(05):308–13.
21. Lawall H. Treatment of chronic wounds. VASA. 2012;41(6):396–409.
22. Rüttermann M, Maier-Hasselmann A, Nink-Grebe B, Burckhardt M. Local treatment of chronic wounds: in patients with peripheral vascular disease, chronic venous insufficiency, and diabetes. Dtsch Ärzteblatt Int. 2013;110(3):25–31.
23. Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol. 2002;46(3):381–6.
24. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl 1):8–16.
25. Garmhausen D, Hagemann T, Bieber T, Dimitriou I, Fimmers R, Diepgen T, Novak N. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy. 2013;68(4):498–506.
26. Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161(1):134–9.
27. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473–91.
28. Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schäfer I. Prevalence of skin lesions and need for treatment in a cohort of 90,880 workers. Br J Dermatol. 2011;165(4):865–73.
29. Smith JA. Qualitative psychology: a practical guide to research methods. London: SAGE Publications Ltd; 2008.
30. Perneger TV, Courvoisier DS, Hudelson PM, Gayet-Ageron A. Sample size for pre-tests of questionnaires. Qual Life Res. 2015;24:147–51.
31. Mayring P. Qualitative Content Analysis. In: Flick U, Kardorff E, Steinke I, editors. A companion to qualitative research. London: Sage Publications; 2004. p. 266–9.
32. Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10:22.